CD8A and neoplasm: As a matter of fact, A2AR activation upregulates PD-1 on tumor-specific CD8+T and Treg cells, whereas its inhibition decreases the expression of PD-L1 on myeloid APCs and PD-1 on both tumor-associated CD8+T and Tregs cells (74, 79, 80).